Cite
HARVARD Citation
Roviello, G. et al. (2021). Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. Therapeutic advances in urology. p. . [Online].